Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $73.77, but opened at $69.78. Tempus AI shares last traded at $67.50, with a volume of 328,322 shares.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on TEM shares. Stifel Nicolaus lowered Tempus AI from a "buy" rating to a "hold" rating and raised their price objective for the company from $45.00 to $65.00 in a research note on Monday. Bank of America lowered shares of Tempus AI from a "buy" rating to a "neutral" rating and boosted their target price for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Needham & Company LLC restated a "buy" rating and issued a $47.00 target price on shares of Tempus AI in a report on Wednesday, August 7th. Loop Capital raised their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research report on Tuesday, October 15th. Finally, Piper Sandler started coverage on shares of Tempus AI in a report on Monday, August 12th. They set a "neutral" rating and a $40.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $50.89.
View Our Latest Stock Report on TEM
Tempus AI Trading Down 4.4 %
The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 3.52. The firm's 50-day simple moving average is $50.22.
Institutional Trading of Tempus AI
Large investors have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. purchased a new stake in shares of Tempus AI in the third quarter valued at approximately $30,000. Sandia Investment Management LP purchased a new stake in Tempus AI in the second quarter valued at about $136,000. Vestor Capital LLC purchased a new stake in Tempus AI during the 3rd quarter worth approximately $153,000. IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new stake in shares of Tempus AI during the third quarter valued at $258,000. Finally, Clarus Group Inc. acquired a new position in shares of Tempus AI in the third quarter valued at about $283,000.
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.